Search Results
Feb 12, 2026, 03:00 ET ACG Packaging Materials tritt dem Global Lighthouse Network des Weltwirtschaftsforums als erstes pharmazeutisches Verpackungsunternehmen der Welt bei
LieferungFür Kunden bedeutet dies kürzere Durchlaufzeiten, weniger Mängel sowie eine zuverlässigere Lieferleistung in großem Maßstab.S R Shivshankar, Geschäftsführer von ACG Packaging Materials, sagte: „Diese Auszeichnung spiegelt das Engagement unserer Teams in Shirwal wider und ihre Fähigkeit,
More news about: ACG
Feb 12, 2026, 03:00 ET ACG Packaging Materials, première société d'emballage pharmaceutique au monde à rejoindre le réseau mondial des phares du Forum économique mondial
livraisonsPour les clients, cela se traduit par des délais de fabrication plus courts, moins de défauts et des livraisons plus fiables à grande échelle.S R Shivshankar, directeur général d'ACG Packaging Materials, a déclaré : « Cette reconnaissance témoigne de l'engagement de nos équipes à Shirwal, et de
More news about: ACG
Feb 12, 2026, 02:46 ET EQT and Blackstone Infrastructure to acquire Urbaser, a leading waste management infrastructure platform
https://news.cision.com/eqt/r/eqt-and-blackstone-infrastructure-to-acquire-urbaser--a-leading-waste-management-infrastructure-plat,c4306582The following files are available for download:
More news about: EQT
Feb 12, 2026, 02:30 ET Hexagon announces update on planned spin-off of Octave
https://news.cision.com/hexagon/r/hexagon-announces-update-on-planned-spin-off-of-octave,c4306402The following files are available for download:
More news about: Hexagon
Feb 12, 2026, 02:00 ET Bracco and ACIST Medical Systems Announce European Launch of ACIST Pro™ Diagnostic System
and contrast volume on risk of contrast-induced nephropathy. Am J Cardiol 113 (1): 49-53.2 Call J, Sacrinty M, Applegate R, Little W, Santos R et al. (2006) Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy.
More news about: Bracco Group
Feb 12, 2026, 02:00 ET Bracco and ACIST Medical Systems Announce European Launch of ACIST Pro™ Diagnostic System
and contrast volume on risk of contrast-induced nephropathy. Am J Cardiol 113 (1): 49-53.2 Call J, Sacrinty M, Applegate R, Little W, Santos R et al. (2006) Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy.
More news about: Bracco Group
Feb 12, 2026, 02:00 ET Betolar, EcoGraf and GTK collaborate to transform Epanko mine tailings using Betolar's metal extraction technology
https://news.cision.com/betolar-oyj/r/betolar--ecograf-and-gtk-collaborate-to-transform-epanko-mine-tailings-using-betolar-s-metal-extract,c4306424The following files are available for download:
More news about: Betolar Oyj
Feb 12, 2026, 01:19 ET Hexagon Agility receives inaugural order for cylinders used in commercial aerospace applications
https://news.cision.com/hexagon-composites-asa/r/hexagon-agility-receives-inaugural-order-for-cylinders-used-in-commercial-aerospace-applications,c4306457
More news about: Hexagon Composites ASA
Feb 12, 2026, 01:19 ET Hexagon Composites ASA: Fourth quarter and full year 2025
https://news.cision.com/hexagon-composites-asa/r/hexagon-composites-asa--fourth-quarter-and-full-year-2025,c4306474The following files are available for download:
More news about: Hexagon Composites ASA
Feb 12, 2026, 00:30 ET Green Pulse Update: MSMEs Accelerate Environmental Action and Strengthen Implementation Momentum
increased by 10% QoQ, led by older and mid-aged businesses, marking the sharpest increase since Q4 2023.MSMEs prioritised Reduce, Reuse, Recycle (3R) (31%) and DEI reforms (25%), over employee welfare (18%) and full compliance with the guidelines and the regulations (11%) in Q3 2025.60% of MSMEs
More news about: Dun & Bradstreet India
Feb 11, 2026, 23:18 ET Novel Anti-Fibrotic Drug AK3280 Cleared by FDA to Initiate Phase 2 Proof-of-Concept Clinical Trial in IPF
therapeutics for respiratory and pediatric diseases. Founded in 2014, the company has established proprietary technology platforms and a differentiated R&D pipeline through internal innovation and strategic collaborations.Key pipeline assets include: Ziresovir (AK0529), the first direct-acting antiviral
More news about: Arkbio
Feb 11, 2026, 23:18 ET Novel Anti-Fibrotic Drug AK3280 Cleared by FDA to Initiate Phase 2 Proof-of-Concept Clinical Trial in IPF
therapeutics for respiratory and pediatric diseases. Founded in 2014, the company has established proprietary technology platforms and a differentiated R&D pipeline through internal innovation and strategic collaborations.Key pipeline assets include: Ziresovir (AK0529), the first direct-acting antiviral
More news about: Arkbio
Feb 11, 2026, 21:35 ET Desay Battery Tercantum dalam Daftar "BNEF Global Energy Storage Tier 1" Selama Empat Tahun Berturut-turut
ditiru di tengah persaingan global yang semakin kompleks dan dinamis."Desay Battery selalu mengutamakan inovasi penelitian dan pengembangan (R&D), serta terus meningkatkan berbagai indikator kinerja utama untuk sistem penyimpanan energi. Kami telah mencapai terobosan dalam densitas energi sel
More news about: HUIZHOU DESAY BATTERY CO.,LTD.
Feb 11, 2026, 20:00 ET NIPPON EXPRESS HOLDINGS收購巴基斯坦TCS Logistics (Private) Limited少數股權
https://drive.google.com/file/d/1dqm0cxpYamnvMUra1AGXMuGlX932Z353/view?usp=drive_link 圖片：https://drive.google.com/file/d/1YnnuMQ4QhY-f8Hpi9r5O-tf_Cq34QwSK/view?usp=drive_link NX集團將提供覆蓋客戶整個供應鏈的端到端解決方案作為加速全球業務增長的關鍵戰略，尤其注重加強南亞及周邊地區的全球物流能力。TCS
More news about: NIPPON EXPRESS HOLDINGS, INC.
Feb 11, 2026, 17:44 ET Monday.com's No-Touch Channel Weakness and AI Investment Costs Were Embedded in Guidance Without Prior Disclosure
mid-to-high 80s in FY2026, attributed in part to AI infrastructure costs. R&D spending rose from 17% to 19% of revenue in FY2025, and management guided for mid-teens percentage headcount growth in FY2026 concentrated in sales and R&D. These investments reduce near-term profitability while the revenue
More news about: Levi & Korsinsky, LLP
Feb 11, 2026, 17:31 ET EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
after resistance to EGFR TKIs emerges remains a major challenge. Common EGFR-sensitizing mutations, such as exon 19 deletions and exon 21 L858R substitutions, are typically treated with drugs like afatinib and osimertinib. These agents differ in efficacy and safety and are categorized
More news about: DelveInsight Business Research, LLP
Feb 11, 2026, 17:22 ET AGC of California Honors 2026 Constructor Award Winners and Installs New Leadership
Million & UnderCaliagua – Disney's Cotino LagoonSpecialty Over $10 MillionRoyal Electric Company – LAX RWY 6L-24R North Airfield Exit Taxiway Utility InfrastructureWalsh Group – Hyperion Advanced Water Purification FacilityBuilder
More news about: Associated General Contractors of California
Feb 11, 2026, 17:02 ET Sun Life declares dividends on Common and Preferred Shares payable in Q1 2026
$0.281250 per shareSeries 8R$0.264375 per share
More news about: Sun Life Financial Inc. - Financial News
Feb 11, 2026, 17:02 ET Sun Life declares dividends on Common and Preferred Shares payable in Q1 2026
$0.281250 per shareSeries 8R$0.264375 per share
More news about: Sun Life Financial Inc. - Financial News
Feb 11, 2026, 17:01 ET Sun Life Reports Fourth Quarter and Full Year 2025 Results
Non-Cumulative Rate Reset Preferred Shares Series 8R (the "Series 8R Shares") on a one-for-one basis and 1,400 of its 6,217,331 Series 8R Shares were converted into Series 9QR Shares on a one-for-one basis. As a result, as of June 30, 2025, SLF Inc. has 8,880,847 Series 8R Shares and 2,319,153 Series 9QR Shares
More news about: Sun Life Financial Inc. - Financial News
Feb 11, 2026, 17:01 ET Sun Life Reports Fourth Quarter and Full Year 2025 Results
Non-Cumulative Rate Reset Preferred Shares Series 8R (the "Series 8R Shares") on a one-for-one basis and 1,400 of its 6,217,331 Series 8R Shares were converted into Series 9QR Shares on a one-for-one basis. As a result, as of June 30, 2025, SLF Inc. has 8,880,847 Series 8R Shares and 2,319,153 Series 9QR Shares
More news about: Sun Life Financial Inc. - Financial News
Feb 11, 2026, 16:05 ET Antisemitism on America's College and University Campuses: Current Conditions and the Federal Response
Peter Kirsanow (R) and
More news about: U.S. Commission on Civil Rights
Feb 11, 2026, 16:01 ET Neurocrine Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026
occupancy at steady state versus the highest approved dose of AUSTEDO XR (48 mg) at steady state.At Neurocrine's R&D Day in December, provided an update on Neurocrine's R&D engine, which remains on track to deliver multiple first- and best-in-class medicines across an industry-leading neuropsychiatry
More news about: Neurocrine Biosciences, Inc.
Feb 11, 2026, 15:28 ET ArisGlobal annonce XDI NavaX Data Intelligence, trois nouveaux agents et NavaX Translation
données provenant de fonctions et de systèmes multiples pour permettre des décisions cohérentes et explicables au sein et à travers l'entreprise de R&D pharmaceutique. Contrairement aux outils qui accélèrent simplement les étapes d'un flux de travail unique, XDI crée une base indépendante du système
More news about: ArisGlobal
Feb 11, 2026, 15:25 ET ArisGlobal kündigt XDI NavaX Data Intelligence, drei neue Agenten und NavaX Translation an
Entscheidungen, schnellere Erkenntnisse und eine wirklich skalierbare Einführung von KI ermöglicht", sagte Ann-Marie Orange, CIO und Global Head of R&D bei ArisGlobal.Die Breakthrough 2026 in Madrid, Spanien, bringt Top-Führungskräfte, Branchenführer und Experten zusammen, um das Thema „Operationalisierung
More news about: ArisGlobal